DGAP-News: MPH Mittelständische Pharma Holding AG: IFRS-results Q1 2014: Sales of EUR 56.17 million, net profit of EUR 2.95 million, profit growth of +46.7 %

        Print
| Source: EQS Group AG
DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s):
Quarter Results/Sales Result
MPH Mittelständische Pharma Holding AG: IFRS-results Q1 2014: Sales of
EUR 56.17 million, net profit of EUR 2.95 million, profit growth of
+46.7 %

30.05.2014 / 08:00

---------------------------------------------------------------------

IFRS-results Q1 2014: Sales of EUR 56.17 million, net profit of EUR 2.95
million, profit growth of +46.7 %

MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0NF697), today
reports its IFRS Group results for the first quarter of 2014.

In the first three months 2014 the MPH Group achieved sales amounting to
EUR 56.17 million (prior-year period: EUR 53.42 million), with thus
representing an increase of +5.1 % compared to the same period of the
previous year. Net profit was EUR 2.95 million (prior-year period: EUR 2.01
million), reaching a margin of 5.2 %. Compared to the previous year profit
growth reached +46.7 %.

About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has
strategically concentrated its activities on the growth segments of the
healthcare market and is aimed to make a contribution towards cutting costs
in the healthcare system.

The focus lies on medicines manufactured on the basis of patent-free and
patent-protected active substances for the therapy of chronic diseases.
Complementary, services for individual patient therapies, aesthetic
surgeries and other medical treatments are offered along the
value-added-chain in the healthcare market.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard
(Open Market) of the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 41,167,155
Listed shares: Preference shares
Number of preference shares in circulation: 19,025,000
ISIN: DE000A0NF697
WKN: A0NF69
Stock symbol: 93MV

Contact: Linda Reichelt
MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
D-10623 Berlin

Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669
E-Mail: ir@mph-ag.de   Web: www.mph-ag.de


End of Corporate News

---------------------------------------------------------------------

30.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                     
Company:     MPH Mittelständische Pharma Holding AG                      
             Fasanenstraße 77                                            
             10623 Berlin                                                
             Germany                                                     
Phone:       030 / 897 308 660                                           
Fax:         030 / 897 308 670                                           
E-mail:      info@mph-ag.de                                              
Internet:    www.mph-ag.de                                               
ISIN:        DE000A0NF697                                                
WKN:         A0NF69                                                      
Listed:      Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in  
             Open Market (Entry Standard)                                
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
271200 30.05.2014